Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary

The use of immunosuppressive therapies for immune-mediated disease is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part...

Full description

Saved in:
Bibliographic Details
Published in:Journal of rheumatology 2019-07, Vol.46 (7), p.751-754
Main Authors: Papp, Kim A, Haraoui, Boulos, Kumar, Deepali, Marshall, John K, Bissonnette, Robert, Bitton, Alain, Bressler, Brian, Gooderham, Melinda, Ho, Vincent, Jamal, Shahin, Pope, Janet E, Steinhart, A Hillary, Vinh, Donald C, Wade, John
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The use of immunosuppressive therapies for immune-mediated disease is associated with an elevated risk of infections and related comorbidities. While many infectious diseases can generally be prevented by vaccines, immunization rates in this specific patient population remain suboptimal, due in part to uncertainty about their efficacy or safety under these clinical situations. To address this concern, a multidisciplinary group of Canadian physicians with expertise in dermatology, gastroenterology, infectious diseases, and rheumatology developed evidence-based clinical guidelines on vaccinations featuring 13 statements that are aimed at reducing the risk of preventable infections in individuals exposed to immunosuppressive and immunomodulatory agents.
ISSN:0315-162X
1499-2752
DOI:10.3899/jrheum.180784